腎と骨代謝 Vol.26 No.3(10)


特集名 尿細管トランスポーターの機能制御と疾患治療─トピックス
題名 Bartter症候群・Gitelman症候群─遺伝性塩類喪失性尿細管機能異常症(salt-losing tubulopathy)
発刊年月 2013年 08月
著者 野津 寛大 神戸大学大学院医学研究科内科系講座小児科学
【 要旨 】 Bartter症候群(BS),Gitelman症候群(GS)は,低カリウム血症,代謝性アルカローシスなどを特徴とする先天性尿細管機能障害に伴う症候群である.これまで,(1) BSは太いヘンレループに存在するチャネルまたは輸送体の障害に伴う疾患でGSは遠位尿細管に存在する輸送体の障害に伴う疾患である,(2) GSでは,BSでは認めない低マグネシウム血症,低カルシウム尿症を認める,という2点の違いにより分類することが可能とされてきた.しかし,近年の研究の結果,これらの2点はいずれも誤りであることが判明し,BSおよびGSと分類する根拠がすでに完全に失われていることが明らかとなった.そのため,これらの疾患を一つの疾患概念へと統合する必要性が明確になり,すでに一部のグループから,salt-losing tubulopathy(遺伝性塩類喪失性尿細管機能異常症;SLT)と総称する必要性が提唱されている.本稿においては,これらの疾患に関係するこれまでの動向と,SLTという新たな統一疾患概念の必要性の根拠につき解説する.
Theme Regulation, disease states and drug targets of kidney tubular transporters -- Topics
Title Bartter's syndrome and Gitelman's syndrome
Author Kandai Nozu Department of Pediatrics, Kobe University Graduate School of Medicine
[ Summary ] Bartter's syndrome and Gitelman's syndrome are inherited salt-losing tubulopathies which lead to hypokalemia and metabolic alkalosis. Our understanding of inherited salt-losing tubulopathies has improved with recent advances in molecular genetics. However, the terminologies related to Bartter’s syndrome and Gitelman's syndrome do not always accurately reflect their pathophysiological basis or clinical presentation. Some cases are difficult to diagnose due to clinical presentations. Basically the difference between these two diseases is described in two ways : 1) Bartter's syndrome is caused by defects in the channels or transporters located on the thick ascending limb of Henle's loop and Gitelman's syndrome is caused by defects in the transporters located on the distal tubules. 2) Gitelman's syndrome patients exhibit hypomagnesemia and hypocalciuria, not seen in Bartter's syndrome patinents. However, recent studies have suggested that type III Bartter's syndrome is derived primarily from defects in the distal tubules. Some type III Bartter's syndrome patients present with hypomagnesemia and hypocaiciuria. Because of these results, these terminologies are thought to be misleading and should be improved upon. Recently, Seyberth has proposed a new terminology combining these two diseases, termed salt-losing tubulopathy. This term is quite reasonable and should be generally accepted.
戻る